ABP-745 Dose B

DRUG2 trials

Sponsors

Atom Therapeutics Co., Ltd

Conditions

ASCVDASCVD ManagementAcute Gout FlareAcute Gouty ArthritisAtherosclerosis Cardiovascular DiseaseGout FlareGout Flares

Phase 2

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

RecruitingNCT07145229

Atom Therapeutics Co., LtdAcute Gout Flare, Acute Gouty Arthritis, Gout Flare +1

Start: 2025-08-26End: 2026-06-30Target: 380Updated: 2025-12-08

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

RecruitingNCT07303777

Atom Therapeutics Co., LtdASCVD, ASCVD Management, Atherosclerosis Cardiovascular Disease

Start: 2026-04-23End: 2028-04-01Target: 200Updated: 2026-04-28